Post-earnings recap
Reported
Thu, Oct 25, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Est. EPS
—
Est. Rev
—
Impl. Move
—
BioMarin's earnings report showed a loss that was larger than expected, which typically raises concerns among investors. However, the stock still rose by 3.82%, likely due to market optimism about the company's long-term potential and management's focus on innovation. Investors may be looking past the current losses in anticipation of future growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.07 | N/A | -157.13% |
| Revenue | N/A | N/A | N/A |
Management acknowledged the difficulties faced in the quarter but expressed confidence in the company's future prospects. They reiterated their focus on innovation and product development.
Management highlighted ongoing challenges in meeting earnings expectations.
They emphasized their commitment to long-term growth despite short-term setbacks.